Stockscreener 앱 받기
60.03
5.60%
-3.56
시장 영업 전:
60.20
0.17
+0.28%
Cytokinetics Inc (CYTK) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
4,129%
66.77
|
1.579 | 0.463 | 0.249 | 0.835 |
Operating Expenses
|
13.40%
178.28
|
157.21 | 141.26 | 130.42 | 127.07 |
| Interest Income/Expense |
24.99%
11.08
|
8.868 | 8.928 | 12.73 | 7.103 |
| Benefits Costs and Expenses |
100.00%
-
|
162.96 | - | - | 136.48 |
| Costs And Expenses |
9.40%
178.28
|
162.96 | 141.26 | 130.42 | 136.48 |
| Operating Income/Loss |
28.35%
-111.51
|
-155.63 | -140.80 | -130.17 | -126.23 |
| Nonoperating Income/Loss |
5.11%
13.00
|
13.70 | 17.05 | 11.55 | 7.913 |
| Income/Loss From Continuing Operations Before Tax |
141.37%
66.77
|
-161.38 | 0.463 | -143.32 | -135.64 |
| Income/Loss From Continuing Operations After Tax |
16.73%
-134.37
|
-161.38 | -160.54 | -143.32 | -135.64 |
|
Net Income/Loss
|
16.73%
-134.37
|
-161.38 | -160.54 | -143.32 | -135.64 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.81%
0.1195
|
0.1185 | 0.1177 | 0.1092 | 0.1019 |
| Diluted Average Shares |
0.81%
0.1195
|
0.1185 | 0.1177 | 0.1092 | 0.1019 |
| Basic Earnings Per Share |
17.65%
-1.12
|
-1.36 | -1.36 | -1.31 | -1.33 |
| Diluted Earnings Per Share |
17.65%
-1.12
|
-1.36 | -1.36 | -1.31 | -1.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
자본화:
|
볼륨(24시간):